Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer

被引：24

作者：

Abderrahman, Balkees ^{[1
]}

Jordan, V. Craig ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA

来源：

JAMA ONCOLOGY | 2018年 / 4卷 / 01期

基金：

美国国家卫生研究院;

关键词：

ESTROGEN-RECEPTOR; RANDOMIZED-TRIAL; TAMOXIFEN;

D O I：

10.1001/jamaoncol.2017.3510

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：15 / 16

页数：2

共 9 条

[1] Angela M. Hartley Brodie (1934-2017) OBITUARY [J].

Abderrahman, Balkees ;

Jordan, V. Craig .

NATURE, 2017, 548 (7665) :32-32

[2] SOLE (Study of Letrozole Extension): A phase III randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC) [J].

Colleoni, Marco ;

Luo, Weixiu ;

Karlsson, Per ;

Chirgwin, Jacqueline H. ;

Aebi, Stefan Paul ;

Jerusalem, Guy Heinrich Maria ;

Neven, Patrick ;

Hitre, Erika ;

Graas, Marie-Pascale ;

Simoncini, Edda ;

Kamby, Claus ;

Thompson, Alastair Mark ;

Loibl, Sibylle ;

Gavila, Joaquin ;

Kuroi, Katsumasa ;

Gnant, Michael ;

Rabaglio-Poretti, Manuela ;

Regan, Meredith M. ;

Coates, Alan S. ;

Goldhirsch, Aron .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35

[3] Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [J].

Davies, Christina ;

Pan, Hongchao ;

Godwin, Jon ;

Gray, Richard ;

Arriagada, Rodrigo ;

Raina, Vinod ;

Abraham, Mirta ;

Medeiros Alencar, Victor Hugo ;

Badran, Atef ;

Bonfill, Xavier ;

Bradbury, Joan ;

Clarke, Michael ;

Collins, Rory ;

Davis, Susan R. ;

Delmestri, Antonella ;

Forbes, John F. ;

Haddad, Peiman ;

Hou, Ming-Feng ;

Inbar, Moshe ;

Khaled, Hussein ;

Kielanowska, Joanna ;

Kwan, Wing-Hong ;

Mathew, Beela S. ;

Mittra, Indraneel ;

Mueller, Bettina ;

Nicolucci, Antonio ;

Peralta, Octavio ;

Pernas, Fany ;

Petruzelka, Lubos ;

Pienkowski, Tadeusz ;

Radhika, Ramachandran ;

Rajan, Balakrishnan ;

Rubach, Maryna T. ;

Tort, Sera ;

Urrutia, Gerard ;

Valentini, Miriam ;

Wang, Yaochen ;

Peto, Richard .

LANCET, 2013, 381 (9869) :805-816

[4] Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCICCTG MA.17 [J].

Goss, PE ;

Ingle, JN ;

Martino, S ;

Robert, NJ ;

Muss, HB ;

Piccart, MJ ;

Castiglione, M ;

Tu, DS ;

Shepherd, LE ;

Pritchard, KI ;

Livingston, RB ;

Davidson, NE ;

Norton, L ;

Perez, EA ;

Abrams, JS ;

Cameron, DA ;

Palmer, MJ ;

Pater, JL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (17) :1262-1271

[5] Tamoxifen: Catalyst for the change to targeted therapy [J].

Jordan, V. Craig .

EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) :30-38

[6] Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer [J].

Jordan, V. Craig ;

Brodie, Angela M. H. .

STEROIDS, 2007, 72 (01) :7-25

[7] Linking Estrogen-Induced Apoptosis With Decreases in Mortality Following Long-term Adjuvant Tamoxifen Therapy [J].

Jordan, V. Craig .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (11)

[8] Predictors of recurrence during years 5-14 in 46,138 women with ER plus breast cancer allocated 5 years only of endocrine therapy (ET). [J].

Pan, Hongchao ;

Gray, Richard G. ;

Davies, Christina ;

Peto, Richard ;

Bergh, Jonas C. S. ;

Pritchard, Kathleen I. ;

Dowsett, Mitch ;

Hayes, Daniel F. .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)

[9] Past, Present, and Future Challenges in Breast Cancer Treatment [J].

Sledge, George W. ;

Mamounas, Eleftherios P. ;

Hortobagyi, Gabriel N. ;

Burstein, Harold J. ;

Goodwin, Pamela J. ;

Wolff, Antonio C. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) :1979-1986

← 1 →